Visit my published paper on the Novel Analgesic Compound, PN6047:
[ Ссылка ]

Southampton, UK-based Synairgen has announced positive results from a clinical trial of SNG001, its wholly-owned inhaled formulation of interferon beta, in hospitalised COVID-19 patients.

If you would like to contribute to Dr. Junaid's educational projects, please use the following number, thank you:
JazzCash/ EasyPaisa: 03498924064

свернуть